Financials Alpha Cognition Inc. Toronto S.E.
Equities
ACOG
CA02074J2048
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% |
|
-.--% | -.--% |
May. 15 | Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 04 | Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 65.46 | 18 | 78.02 | 108.4 | - |
Enterprise Value (EV) 1 | 65.46 | 18 | 78.02 | 108.4 | 108.4 |
P/E ratio | -2.27 x | -1.19 x | - | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 4.01 x |
EV / Revenue | - | - | - | - | 4.01 x |
EV / EBITDA | -4.26 x | -0.98 x | -5.89 x | -36.1 x | 36.1 x |
EV / FCF | -5,156,407 x | -1,435,639 x | - | - | - |
FCF Yield | -0% | -0% | - | - | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 60,607 | 61,023 | 118,209 | 150,506 | - |
Reference price 2 | 1.080 | 0.2950 | 0.6600 | 0.7200 | 0.7200 |
Announcement Date | 4/28/22 | 3/8/23 | 4/3/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 27 |
EBITDA 1 | -15.36 | -18.32 | -13.24 | -3 | 3 |
EBIT | -15.52 | -18.5 | - | - | - |
Operating Margin | - | - | - | - | - |
Earnings before Tax (EBT) | -25.08 | -16.7 | - | - | - |
Net income | -25.08 | -16.7 | - | - | - |
Net margin | - | - | - | - | - |
EPS | -0.4748 | -0.2482 | - | - | - |
Free Cash Flow | -12.69 | -12.54 | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 4/28/22 | 3/8/23 | 4/3/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT | -5.457 | - | -5.717 | -3.843 | -4.639 | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | -4.041 | - | -3.887 | -2.791 | -5.676 | - | - | - | - | - | - | - | - | - | - |
Net income | -4.041 | - | -3.887 | -2.791 | -5.676 | - | -3.781 | - | - | -6.823 | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | -0.0898 | - | -0.0647 | -0.0538 | -0.0689 | - | -0.0406 | - | - | -0.0410 | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 4/28/22 | 5/30/22 | 8/25/22 | 11/28/22 | 3/8/23 | 5/30/23 | 8/22/23 | 11/28/23 | 4/3/24 | 5/14/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | -12.7 | -12.5 | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | 0.02 | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 4/28/22 | 3/8/23 | 4/3/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+22.15% | 46.56B | |
+45.15% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- ACOG Stock
- ACOG Stock
- Financials Alpha Cognition Inc.